Literature DB >> 27631348

Evaluation of Visual Quality in Patients With Fuchs Endothelial Corneal Dystrophy.

Yoshinori Oie1, Shinya Watanabe, Kohji Nishida.   

Abstract

Fuchs endothelial corneal dystrophy (FECD) is a bilateral corneal endothelial dystrophy characterized by the deposition of extracellular matrix (guttae), thickening of Descemet membrane, and progressive loss of corneal endothelial cells. Progressive endothelial cellular loss leads to corneal edema and impairs visual function. In eyes with FECD, corneal edema begins in the central cornea and expands into the periphery. FECD is the most common dystrophic reason for corneal transplantation in many countries. Some patients with FECD report visual discomfort despite the absence of corneal edema. Intraocular forward light scatter impairs patients' quality of vision (QOV), and corneal guttae associated with FECD may cause intraocular light scatter and glare, which can be extremely debilitating despite the absence of edema. We recently investigated the effect of the severity of corneal guttae on QOV in patients with mild FECD. It was shown that corneal guttae increased forward light scatter that negatively affected QOV in eyes with mild FECD without severe corneal edema. Therefore, quantification of corneal guttae would be useful to determine surgical indications for eyes with mild FECD. This review discusses QOV in patients with FECD.

Entities:  

Mesh:

Year:  2016        PMID: 27631348     DOI: 10.1097/ICO.0000000000000994

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Association of the Gutta-Induced Microenvironment With Corneal Endothelial Cell Behavior and Demise in Fuchs Endothelial Corneal Dystrophy.

Authors:  Viridiana Kocaba; Kishore Reddy Katikireddy; Ilene Gipson; Marianne O Price; Francis W Price; Ula V Jurkunas
Journal:  JAMA Ophthalmol       Date:  2018-08-01       Impact factor: 7.389

2.  Descemet membrane endothelial keratoplasty (DMEK) improves vision-related quality of life.

Authors:  Alexandra Gellert; Jan Darius Unterlauft; Matus Rehak; Christian Girbardt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-25       Impact factor: 3.535

3.  Cataract surgery in patients with Fuchs' dystrophy and corneal decompensation indicated for Descemet's membrane endothelial keratoplasty.

Authors:  Wei-Yi Chou; Yih-Shiuan Kuo; Pei-Yu Lin
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

Review 4.  Phacoemulsification in the Setting of Corneal Endotheliopathies: A Review.

Authors:  Victoria S Chang; Allister Gibbons; Carla Osigian
Journal:  Int Ophthalmol Clin       Date:  2020

5.  Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy-Analysis of 130 Eyes of 65 Subjects.

Authors:  Kitti Kormányos; Klaudia Kovács; Orsolya Németh; Gábor Tóth; Gábor László Sándor; Anita Csorba; Cecília Nóra Czakó; László Módis; Achim Langenbucher; Zoltán Zsolt Nagy; Gergely Varga; László Gopcsa; Gábor Mikala; Nóra Szentmáry
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

6.  Descemet membrane endothelial keratoplasty (DMEK): an update on safety, efficacy and patient selection.

Authors:  Bruno Lovaglio Cançado Trindade; Glauber Coutinho Eliazar
Journal:  Clin Ophthalmol       Date:  2019-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.